Uterine isthmocele or uterine niche is a late complication of cesarean deliveries and causes chronic pelvic pain, menorrhagia or postmenstrual spotting, and infertility. As the number of cesarean sections are constantly increasing, it is important to be aware of this entity so as to make an early diagnosis. This would enable the clinicians to manage these patients efficiently. We present three patients of uterine isthmocele who were evaluated and managed at our institution.
PMID 34790304 34790304 DOI 10.1055/s-0041-1736393 10.1055/s-0041-1736393
Cite this article
Rupa, R., kushvaha, S., & Venkatesh, K. (2021). Uterine Isthmocele-A Frequently Overlooked Complication of Cesarean Sections. The Indian journal of radiology & imaging, 31(3), 601-604. https://doi.org/10.1055/s-0041-1736393
Rupa R, kushvaha S, Venkatesh K. Uterine Isthmocele-A Frequently Overlooked Complication of Cesarean Sections. Indian J Radiol Imaging. 2021;31(3):601-604. doi:10.1055/s-0041-1736393
Rupa, Rosita, et al. "Uterine Isthmocele-A Frequently Overlooked Complication of Cesarean Sections." The Indian journal of radiology & imaging, vol. 31, no. 3, 2021, pp. 601-604.
Streit-Ciećkiewicz D et al., 2022·Int J Environ Res Public Health
Regenerative medicine combines elements of tissue engineering and molecular biology aiming to support the regeneration and repair processes of damaged tissues, cells and organs. The most commonly used preparation in regenerative medicine is platelet rich plasma (PRP) containing numerous growth factors present in platelet granularities. This therapy is increasingly used in various fields of medicine. This article is a review of literature on the use of PRP in gynecology and obstetrics. There is no doubt that the released growth factors and proteins have a beneficial effect on wound healing and regeneration processes. So far, its widest application is in reproductive medicine, especially in cases of thin endometrium, Asherman's syndrome, or premature ovarian failure (POF) but also in wound healing and lower urinary tract symptoms (LUTS), such as urinary incontinence or recurrent genitourinary fistula auxiliary treatment. Further research is, however, needed to confirm the effectiveness and the possibility of its application in many other disorders.
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
The PEARS (Pelvic Endoscopic Adhesion-Related Surgery) procedure for peritoneal and ovarian endometriosis combines near-contact laser vaporization, adhesiolysis, and ovarian cystectomy under strict anti-adhesion protocols to achieve comprehensive disease eradication while preserving ovarian reserve. Outcomes data demonstrate superior fertility and pain resolution compared to incomplete surgical approaches, establishing PEARS as the operative standard within NaProTECHNOLOGY.
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
Uterine fibroids contribute to abnormal uterine bleeding, dysmenorrhea, recurrent pregnancy loss, and implantation failure, making myomectomy a central NaProTECHNOLOGY surgical intervention for women seeking conception. PEARS myomectomy technique prioritizes uterine preservation, meticulous layered closure of the myometrial defect, and hemostasis strategies that minimize adhesion formation and support subsequent pregnancy.
The primary objective of polycystic ovarian syndrome (PCOS) treatment is to achieve mono-ovulatory cycles, thereby enabling pregnancy and childbirth. Laparoscopic ovarian drilling (LOD) and transvaginal ovarian drilling (TVOD) are widely used second-line treatments for ovulation induction in PCOS patients who do not respond to clomiphene citrate (CC). LOD involves the application of heat or laser energy to create small perforations in the ovary, whereas TVOD involves ultrasound-guided ovarian puncture. Both LOD and TVOD have been shown to be effective in promoting ovulation and enhancing fertility outcomes in PCOS patients. TVOD offers several potential advantages over LOD, including a lower risk of surgical complications, reduced cost, and the ability to be performed in an outpatient setting. Both LOD and TVOD are effective treatment options for PCOS-related infertility. The choice between the two procedures should be based on individual patient characteristics, including body mass index (BMI), hormonal profiles, and previous responses to treatment. Further research is needed to optimize these techniques and clarify their clinical applications. Patients with clomiphene-resistant PCOS should be carefully assessed for both LOD and TVOD. LOD may be more suitable for patients with elevated luteinizing hormone (LH) levels and shorter durations of infertility. In contrast, TVOD may be preferred for patients who would benefit from a less invasive approach with a lower risk of adhesion formation.